Renal-hepatic-pancreatic dysplasia syndrome (ivemark's syndrome)
- 11k Downloads
Renal-Hepatic-Pancreatic dysplasia syndrome described by Ivemark in 1959 constitutes a triad pancreatic fibrosis, renal dysplasia and hepatic dysgenesis.
We describe two unrelated cases of Renal-Hepatic-Pancreatic dysplasia syndrome in stillborn babies. The characteristic microscopic features were present in both the cases. The second case illustrates the unique association lymphangiectasia with Renal-Hepatic-Pancreatic dysplasia syndrome. Both cases are unrelated and there is no history of any consanguineous marriage.
These two cases are unrelated and are rare. In the developmental research, the perinatal autopsy needs to be utilized as a major tool and an Ad hoc committee formation is required to formulate the approach towards syndromic diseases.
KeywordsPolydactyly Renal Dysplasia Early Neonate Period Serous Effusion Congenital Hepatic Fibrosis
Renal-Hepatic-Pancreatic dysplasia syndrome is a rare sporadic or autosomal recessive disorder characterized by pancreatic fibrosis, renal dysplasia and hepatic dysgenesis. This triad constitutes a "dysplastic sequence" and was first reported by Ivemark et al as "familial dysplasia of kidneys, liver and pancreas" in 1959 . Renal-Hepatic-Pancreatic dysplasia syndrome is uniformly fatal. Most of the deaths occur in their early neonate period. The molecular basis for the defect in the development of epithelial cell of ductular system in renal, hepatic, and pancreas remains unknown. Herein, we describe two stillborn cases with characteristic features of Renal-Hepatic-Pancreatic dysplasia syndrome.
Case summary 1
A 28-year-old primigravida in the 33rd week of gestation was admitted to the obstetric services with one-day history of abdominal pain and bleeding per vaginum. She did not have any regular antenatal check-up; however, the antenatal period was uneventful. There was no history of consanguinity, drug intake or exposure to radiation in the first trimester. Examination revealed palpable uterus up to xyphisternum, breech presentation and pervaginal bleeding. Fetal heart sounds were audible but feeble. A clinical diagnosis of abruptio placenta was made and labor was induced. A fresh stillborn baby boy weighing 1.4 Kg was delivered. Informed consent was obtained for a complete autopsy.
Case summary 2
A 24-year-old in the 36th week of gestation was admitted to the obstetric services with loss of fetal movements. Her antenatal check-up at 28 weeks had revealed fetal ascites, scalp edema and cystic kidneys on ultrasound examination. There was no history of consanguinity. A clinical diagnosis of intra-uterine fetal death was suspected secondary to complicated breech presentation, and was taken for emergency lower segment caesarian section. A fresh stillborn baby boy weighing 1.4 Kg was delivered. Informed consent was obtained for a complete autopsy.
Renal-Hepatic-Pancreatic dysplasia syndrome is a rare sporadic or autosomal recessive disorder characterized by pancreatic fibrosis, renal dysplasia and hepatic dysgenesis. Ivemark et al first reported it as "familial dysplasia of kidneys, liver and pancreas" in 1959 . Since then, this combination of abnormalities has also been named "polycystic dysplasia" and "renal-hepatic-pancreatic dysplasia". This is to avoid confusion with asplenia-cardiac anomaly syndrome, which was reviewed by Ivemark et al and also bears Ivemark's name. Renal dysplasia in Renal-Hepatic-Pancreatic dysplasia syndrome becomes apparent at 16 weeks of gestation and progresses thereafter in severity. It is characterized by disturbance in glomerular differentiation, delay in tubular differentiation and abnormal expression of epithelial markers in glomeruli and tubules . There are reports in the literature in which this syndrome has been picked up by prenatal ultrasonography as early as at 18 weeks gestation . Renal-Hepatic-Pancreatic dysplasia syndrome is uniformly fatal. Most of the deaths occur in their early neonate period. Those who survive the newborn period, the clinical and functional reflection of these include renal insufficiency, chronic jaundice, and insulin-dependent diabetes mellitus.
The average number of perinatal deaths per year in our institute is 306 over the last 5 years, out which 89% undergo autopsy. Both of our cases had the characteristic findings of Renal-Hepatic-Pancreatic dysplasia syndrome i.e., dysplasia involving kidneys, pancreas and liver. The pancreatic dysplasia is more severe in our cases than in those of Ivemark et al. The pelvicalyceal architecture was maintained, thereby ruling out the possibility of obstructive dysplasia as the etiology. In addition, case 2 had external abnormalities like congenital talipes equino-varus deformity, serous effusions, marked extramedullary hematopoesis and lymphangiectasia in the lungs. The association of lymphangiectasia with Renal-Hepatic-Pancreatic dysplasia syndrome is not known.
The two siblings described by Ivemark et al died with renal failure several weeks after birth. These children had bilateral dysplastic kidneys, congenital hepatic fibrosis, and dysplasia of the pancreas without grossly visible cysts . The case described by Strayer et al is a similar variant of Ivemark syndrome in a 1-day-old child . This patient had large pancreatic cyst, multiple large hepatic cysts, congenital hepatic fibrosis, bilateral dysplastic kidneys, and dysplasia of the pancreas.
Cystic changes of these three organs may be an isolated entity or may occur as a final common pathway of response to a variety of developmental disturbances in various polymalformation syndromes. Experimental studies in the pregnant rats have shown that cysts develop in kidney collecting tubules, bile ducts, & pancreatic ducts after administration of a Na/K ATPase blocker, suggesting a common ductular developmental mechanism . Schrick et al have shown in mouse model that absence of ADP-ribosylation factor-like 3 is associated with abnormal epithelial cell proliferation and cyst formation in the renal, hepatic and pancreatic epithelial tubule structures .
The polymalformation syndromes include Meckel syndrome, Dandy-Walker cyst, Jeune, trisomy 9, Saldino-Noonan, and Elejalde types of chondrodysplasia, and glutaric aciduria II [7, 8]. In Meckel syndrome, extensive deformitives involve the occipital neural tube defects, enlarged cystic kidneys, polydactyly, and other rare sites like liver, heart, and pancreas are seen. Abnormalities of the genital tract have also been described. In addition to the dysplastic kidneys, some cases have been described in which cysts and fibrosis of the liver and even cysts of the pancreas were present . The classical triad of Meckel syndrome described earlier was occipital neural tube defect, enlarged cystic kidneys and polydactyly. The bile duct plate abnormality in the liver is a constant feature . The Meckel syndrome would make an attractive diagnosis in case 2 since it had few of the described deformities of Meckel syndrome. However, the characteristic features of dysplasia in kidney, pancreas and liver and absence of neural defects favour Renal-Hepatic-Pancreatic dysplasia syndrome. Lower cervical neural tube defects occur in Dandy-Walker cyst . The kidneys in autosomal recessive polycystic disease (ARPKD) are enlarged, with fusiform cysts throughout the renal parenchyma running perpendicular to the cortex. No dysplasia is seen in ARPKD. In glutaric aciduria type II, cysts are evident grossly in the liver, and fat infiltration is a consistent feature. Renal lesions are less apparent . Appropriate metabolic tests would help in arriving to the correct diagnosis. The other syndromes have glomerulocystic lesions in the kidney, in excess to the dysplasia.
As highlighted by Bendon RW, there should be formation of Ad hoc committee to facilitate the utilization of the perinatal autopsy in developmental research .
- 10.Blankenberg TA, Ruebner BH, Ellis WG, Bernstein J, Dimmick JE: Pathology of renal and hepatic anomalies in Meckel syndrome. Am J Med Genet. 1987, 395-410. 10.1002/ajmg.1320280546. Suppl 3Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.